Ulinastatin API
Introduction
Ulinastatin is a protease inhibitor derived from proteins in the urine of healthy individuals. It has shown efficacy in treating a variety of medical conditions. While primarily used in Asia, especially Japan and China, its therapeutic potential is gaining global attention.
- CAS Number: 80449-31-6
- Standards: In-House / IP / EP / BP
Product Details
Ulinastatin is a glycoprotein consisting of 143 amino acids and acts as a high-potency protease inhibitor. Its inhibitory spectrum includes:
▸ Pancreatic serine proteases (eg, trypsin, chymotrypsin)
▸ Inflammatory-related enzymes (eg, neutrophil elastase, hyaluronidase)
▸ Tissue-damaging enzymes (eg, thiolase, plasmin)
Advantages
1.Broad Therapeutic Applications
Ulinastatin is indicated for inflammatory and tissue-injury-related diseases, including:
▸ Sepsis
▸ Acute pancreatitis
▸ Trauma and burn-induced inflammation
▸ Other severe inflammatory disorders
Its mechanism focuses on inhibiting pro-inflammatory and proteolytic enzymes, reducing inflammation and accelerating tissue recovery.
2. Excellent Safety Profile
▸ Suitable for all ages, including infants and the elderly
▸ Minimal toxicity and low incidence of adverse reactions
▸ High tolerability for sensitive patients
3. Cost-Effective & Easy Administration
▸ Competitive cost-performance reduces economic burden
▸ Administered via IV injection or infusion without specialized equipment
Summary
Ulinastatin API offers broad therapeutic coverage, excellent safety, and ease of use, providing a reliable solution for managing inflammatory and tissue-damage conditions. Ongoing research continues to expand its potential applications in related therapeutic areas.
Hot Tags: api ulinastatin for human use cas: 86449 - 31 - 6, China api ulinastatin for human use cas: 86449 - 31 - 6 manufacturers, suppliers, factory, consistent peptides, api environmental sustainability, adaptable proteins, api integrations for construction companies, diagnostic peptides, peptide products
